Temat: "Male" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: The associates of anxiety among lung cancer patients: Dehydroepiandrosterone (DHEA) as a potential biomarker.
Autorzy:: Wu JR; Department of Psychiatry, Chang Gung Memorial Hospital, 6, Sec. West Chia-Pu Road, 613, Pu-Zi City, Chiayi County, Taiwan.
Chen VC; Department of Psychiatry, Chang Gung Memorial Hospital, 6, Sec. West Chia-Pu Road, 613, Pu-Zi City, Chiayi County, Taiwan.; School of Medicine, Chang Gung University, 259 Wen-Hwa 1st Road, Kwei-Shan Tao-Yuan, Taiwan.
Fang YH; Division of Thoracic Oncology, Department of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, 6, Sec. West Chia-Pu Road, 613, Pu-Zi City, Chiayi County, Taiwan.
Hsieh CC; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang-Gung University, 259 Wen-Hwa 1st Road, Kwei-Shan Tao-Yuan, Taiwan.; Department of Surgery, Chang-Gung Memorial Hospital, 6, Sec. West Chia-Pu Road, 613, Pu-Zi City, Chiayi County, Taiwan.
Wu SI; Department of Medicine, Mackay Medical College, No.46, Sec.3, Zhongzheng Rd., Sanzhi Dist, 25245, New Taipei City, Taiwan. .; Department of Psychiatry, Mackay Memorial Hospital, No. 92, Sec. 2, Zhongshan N. Rd., Zhongshan Dist., 104, Taipei City, Taiwan. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 15; Vol. 24 (1), pp. 476. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:: Journal Article
MeSH Terms:: Dehydroepiandrosterone*/analysis
Lung Neoplasms*/complications
Male ; Humans ; Female ; Middle Aged ; Dehydroepiandrosterone Sulfate/analysis ; Quality of Life ; Anxiety/epidemiology ; Hydrocortisone ; Fatigue ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: The characteristics and prognosis of different disease patterns of multiple primary lung cancers categorized according to the 8th edition lung cancer staging system.
Autorzy:: Wang Y; Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Fang L; Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Hu X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China.
Wu H; Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. .
Zhou L; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xue Q; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Gao S; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
He J; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. .; Pokaż więcej
Źródło:: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Apr 10; Vol. 19 (1), pp. 200. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*
Neoplasms, Second Primary*/pathology
Neoplasms, Multiple Primary*/pathology
Humans ; Male ; Female ; Neoplasm Staging ; Retrospective Studies ; Prognosis ; Lung/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Radiotherapy combined with anti-PD-1 and TKI for primary cardiac angiosarcoma considering the joint assessment of TLSs and PD-L1: a case report.
Autorzy:: Deng S; Department of Pathology, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150086, China.
Yang X; Precision Medical Center, Harbin Medical University Cancer Hospital, Harbin, China.
He L; Department of stomatology, Heilongjiang provincial hospital, Harbin, China.
Zhang Q; Department of Abdominal Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
Zhao C; Department of Gastrointestinal Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Meng H; Department of Pathology, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150086, China. .; Pokaż więcej
Źródło:: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Apr 09; Vol. 19 (1), pp. 194. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Tertiary Lymphoid Structures*
Hemangiosarcoma*/diagnosis
Hemangiosarcoma*/therapy
Lung Neoplasms*/pathology
Male ; Humans ; Middle Aged ; B7-H1 Antigen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Autorzy:: Illini O; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Bruenner Straße 68, A-1210 Vienna, Austria.; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.
Saalfeld FC; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases, 01307 Dresden, Germany.; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.
Christopoulos P; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Thoraxklinik and Translational Lung Research Center (TLRC), member of the German Center for Lung Research (DZL), Heidelberg University Hospital, 69126 Heidelberg, Germany.
Duruisseaux M; Respiratory Department and Early Phase, Louis Pradel Hospital, Hospices Civils de Lyon Cancer Institute, 69002 Lyon, France.; Oncopharmacology Laboratory, Cancer Research Center of Lyon, Unité Mixte de Recherche (UMR), Institut National de la Santé et de la Recherche Médicale (INSERM), 1052 Centre National de la Recherche Scientifique (CNRS), 5286 Lyon, France.; Université Claude Bernard, Université de Lyon, 69622 Villeurbanne cedex, France.
Vikström A; Department of Pulmonary Medicine, University Hospital Linköping, 58185 Linköping, Sweden.
Peled N; The Hemsely Cancer Center, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
Demedts I; Department of Pulmonary Diseases, AZ Delta, Deltalaan 1, 8800 Roeselare, Belgium.
Dudnik E; Head, Thoracic Oncology Service, Assuta Medical Centers, Tel-Aviv 6329302, Israel.; Faculty of Health Sciences, Ben-Gurion Unversity of the Negev, Be'er Sheva 84105, Israel.
Eisert A; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.
Hashemi SMS; Department of Pulmonary Medicine, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, 1081 Amsterdam, The Netherlands.
Janzic U; Medical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.; Medical Oncology Unit, University Clinic Golnik, 4204 Golnik, Slovenia.
Kian W; The Hemsely Cancer Center, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.; Institute of Oncology, Assuta Ashdod University Hospital, Ashdod 7747629, Israel.
Mohorcic K; Medical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.
Mohammed S; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Kent TN24QJ, UK.
Silvoniemi M; Department of Pulmonary Diseases, Turku University Hospital, University of Turku, 20014 Turku, Finland.
Rothschild SI; Center for Oncology & Hematology and Comprehensive Cancer Center, Cantonal Hospital Baden, 5404 Baden, Switzerland.
Schulz C; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Internal Medicine II, University Hospital, 93053 Regensburg, Germany.
Wesseler C; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Pneumology, Asklepios Tumorzentrum Hamburg, Klinikum Harburg, 21075 Hamburg, Germany.
Addeo A; Oncology Department, University Hospital Geneva, 1205 Geneva, Switzerland.
Armster K; Department of Pneumology, Universitätsklinikum Krems, 3500 Krems an der Donau, Austria.
Itchins M; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.; Northern Clinical School, University of Sydney, St Leonards, NSW 2065, Australia.
Ivanović M; Department of Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia.
Kauffmann-Guerrero D; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Division of Respiratory Medicine and Thoracic Oncology, Department of Medicine V, Thoracic Oncology Center Munich, University Hospital, University of Munich (LMU), 81377 Munich, Germany.
Koivunen J; Department of Oncology and Radiotherapy, Oulu University Hospital, 90014 Oulu, Finland.; Cancer and Translational Medicine Research Unit, University of Oulu, 90014 Oulu, Finland.; Medical Research Center Oulu, 90014 Oulu, Finland.
Kuon J; Department Thoracic Oncology, SLK Fachklinik Löwenstein, 74245 Löwenstein, Germany.
Pavlakis N; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.; Northern Clinical School, University of Sydney, St Leonards, NSW 2065, Australia.
Piet B; Department of Respiratory Medicine, Radboudumc, 6225 GA Nijmegen, The Netherlands.
Sebastian M; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Medicine, Hematology/Oncology, University Hospital, University of Frankfurt, 60596 Frankfurt am Main, Germany.
Velthaus-Rusik JL; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Wannesson L; Istituto Oncologico della Svizzera Italiana, 6500 Bellinzona, Switzerland.
Wiesweg M; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; West German Cancer Center, Department of Medical Oncology, University Duisburg-Essen, 45147 Essen, Germany.
Wurm R; Division of Pulmonology, Department of Internal Medicine, LKH-Universitätsklinikum, Medical University of Graz, 8036 Graz, Austria.
Albers-Leischner C; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Aust DE; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.
Janning M; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, 68167 Mannheim, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Center for Lung Research (DZL), 69120 Heidelberg, Germany.
Fabikan H; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.
Herold S; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.
Klimova A; Core Unit for Data Management and Analytics, National Center for Tumor Diseases, 01307 Dresden, Germany.
Loges S; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, 68167 Mannheim, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Center for Lung Research (DZL), 69120 Heidelberg, Germany.
Sharapova Y; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, 68167 Mannheim, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Center for Lung Research (DZL), 69120 Heidelberg, Germany.
Schütz M; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.
Weinlinger C; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.
Valipour A; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Bruenner Straße 68, A-1210 Vienna, Austria.; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.
Overbeck TR; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen University, 37075 Göttingen, Germany.
Griesinger F; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Hematology and Oncology, Pius University Hospital, University Medicine Oldenburg, 26121 Oldenburg, Germany.
Jakopovic M; Department for Respiratory Diseases Jordanovac, University Hospital Center Zagreb, 10000 Zagreb, Croatia.; School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Hochmair MJ; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Bruenner Straße 68, A-1210 Vienna, Austria.; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.
Wermke M; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases, 01307 Dresden, Germany.; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 03; Vol. 25 (7). Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Aniline Compounds*
Indoles*
Pyrimidines*
Male ; Humans ; Female ; Aged ; ErbB Receptors/genetics ; Exons

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Association of PD-L1 expression with driver gene mutations and clinicopathological characteristics in non-small cell lung cancer: A real-world study of 10 441 patients.
Autorzy:: Ruiz G; Pathology & Molecular Biology Laboratories, Biomakers, Buenos Aires, Argentina.
Enrico D; Thoracic Oncology Unit, Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina.; Clinical Research Unit, Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina.
Mahmoud YD; Universidad Argentina de la Empresa (UADE), Instituto de Tecnología (INTEC), Buenos Aires, Argentina.; Laboratorio de Glicomedicina, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Ruiz A; Pathology & Molecular Biology Laboratories, Biomakers, Buenos Aires, Argentina.
Cantarella MF; Pathology & Molecular Biology Laboratories, Biomakers, Buenos Aires, Argentina.
Leguina L; Pathology & Molecular Biology Laboratories, Biomakers, Buenos Aires, Argentina.
Barberis M; Pathology & Molecular Biology Laboratories, Biomakers, Buenos Aires, Argentina.
Beña A; Pathology & Molecular Biology Laboratories, Biomakers, Buenos Aires, Argentina.
Brest E; Pathology & Molecular Biology Laboratories, Biomakers, Buenos Aires, Argentina.
Starapoli S; Pathology & Molecular Biology Laboratories, Biomakers, Buenos Aires, Argentina.
Mendoza Bertelli A; Pathology & Molecular Biology Laboratories, Biomakers, Buenos Aires, Argentina.
Tsou F; Thoracic Oncology Unit, Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina.; Clinical Research Unit, Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina.
Pupareli C; Thoracic Oncology Unit, Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina.; Clinical Research Unit, Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina.
Coppola MP; Medical Oncology Unit, Hospital Zonal Especializado en Agudos y Crónicos Dr. Antonio Cetrangolo, Buenos Aires, Argentina.
Scocimarro A; Medical Oncology Unit, Hospital Zonal Especializado en Agudos y Crónicos Dr. Antonio Cetrangolo, Buenos Aires, Argentina.
Sena S; Medical Oncology Department, Hospital Alemán, Buenos Aires, Argentina.
Levit P; Medical Oncology Unit, Unión Personal-Accord Salud, Buenos Aires, Argentina.
Perfetti A; Medical Oncology Unit, Unión Personal-Accord Salud, Buenos Aires, Argentina.; Medical Oncology Department, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina.
Aman E; Medical Oncology Unit, Swiss Medical Group, Buenos Aires, Argentina.
Girotti MR; Pathology & Molecular Biology Laboratories, Biomakers, Buenos Aires, Argentina.; Universidad Argentina de la Empresa (UADE), Instituto de Tecnología (INTEC), Buenos Aires, Argentina.
Arrieta O; Head of Thoracic Oncology Unit, Unidad Funcional de Oncología Torácica, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.
Martín C; Thoracic Oncology Unit, Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina.; Clinical Research Unit, Department of Medical Oncology, Alexander Fleming Cancer Institute, Buenos Aires, Argentina.
Salanova R; Pathology & Molecular Biology Laboratories, Biomakers, Buenos Aires, Argentina.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Apr; Vol. 15 (11), pp. 895-905. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Adenocarcinoma*/genetics
Male ; Humans ; Protein-Tyrosine Kinases/genetics ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Retrospective Studies ; Anaplastic Lymphoma Kinase/genetics ; Proto-Oncogene Proteins/genetics ; Mutation ; ErbB Receptors/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: PD-L1 Expression in Ampullary Adenocarcinoma.
Autorzy:: Siddiqui SH; Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Kumari N; Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India.
Mishra S; Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Radha P; Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Mohindra S; Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Singh RK; Department of Surgical Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Krishnani N; Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.; Pokaż więcej
Źródło:: International journal of surgical pathology [Int J Surg Pathol] 2024 Apr; Vol. 32 (2), pp. 263-272. Date of Electronic Publication: 2023 Jun 08.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*
Adenocarcinoma*/drug therapy
Duodenal Neoplasms*/drug therapy
Pancreatic Neoplasms*
Common Bile Duct Neoplasms*
Male ; Humans ; Female ; B7-H1 Antigen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study.
Autorzy:: Wei Q; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Deng T; Pulmonary and Critical Care Medicine, Guang 'an People's Hospital, Guang 'an, China.
Wu J; Respiratory and Critical Care Medicine, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, China.
Zeng H; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Qi C; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Tan S; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhang Y; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Huang Q; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Pu X; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Xu W; Respiratory and Critical Care Medicine, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, China.
Li W; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Tian P; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China. .; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China. .
Li Y; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China. .; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 28; Vol. 24 (1), pp. 393. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/complications
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/complications
Lung Neoplasms*/drug therapy
Pleural Effusion, Malignant*/drug therapy
Pleural Effusion, Malignant*/pathology
Humans ; Male ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Immune Checkpoint Inhibitors/adverse effects ; Retrospective Studies ; Female

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: In silico analysis of overall survival with YBX1 in male and female solid tumours.
Autorzy:: Grimes DR; Applied Radiation Therapy Trinity, Discipline of Radiation Therapy, Trinity College Dublin, Dublin, Ireland.
Rassamegevanon T; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Marignol L; Applied Radiation Therapy Trinity, Discipline of Radiation Therapy, Trinity College Dublin, Dublin, Ireland. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7218. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; Male ; Female ; Y-Box-Binding Protein 1/genetics ; Y-Box-Binding Protein 1/metabolism ; Gene Expression Regulation, Neoplastic ; Cell Proliferation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Reproductive factors and risk of lung cancer among 300,000 Chinese female never-smokers: evidence from the China Kadoorie Biobank study.
Autorzy:: Elbasheer MMA; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Bohrmann B; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Chen Y; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Medical Research Council (MRC) Population Health Research Unit (MRC PHRU), University of Oxford, Oxford, UK.
Lv J; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.; Center for Public Health and Epidemic Preparedness & Response, Peking University, Beijing, China.; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.
Sun D; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.; Center for Public Health and Epidemic Preparedness & Response, Peking University, Beijing, China.; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.
Wu X; Pengzhou Centre for Disease Control and Prevention (CDC), Pengzhou, China.
Yang X; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Avery D; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Li L; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.; Center for Public Health and Epidemic Preparedness & Response, Peking University, Beijing, China.; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.
Chen Z; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Medical Research Council (MRC) Population Health Research Unit (MRC PHRU), University of Oxford, Oxford, UK.
Kartsonaki C; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Medical Research Council (MRC) Population Health Research Unit (MRC PHRU), University of Oxford, Oxford, UK.
Chan KH; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Oxford BHF Centre of Research Excellence, University of Oxford, Oxford, UK.
Yang L; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK. .; Medical Research Council (MRC) Population Health Research Unit (MRC PHRU), University of Oxford, Oxford, UK. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 26; Vol. 24 (1), pp. 384. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*
Reproductive History*
Adult ; Female ; Humans ; Biological Specimen Banks ; China/epidemiology ; Contraceptives, Oral ; Prospective Studies ; Risk Factors ; Male ; Non-Smokers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer.
Autorzy:: Levy A; Department of Radiation Oncology, Gustave Roussy, 114 Rue E. Vaillant, 94850, Villejuif, France. .; INSERM U1030, Radiothérapie Moléculaire, Villejuif, France. .; Faculty of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, France. .
Morel D; Department of Radiation Oncology, Gustave Roussy, 114 Rue E. Vaillant, 94850, Villejuif, France.; INSERM U1030, Radiothérapie Moléculaire, Villejuif, France.
Texier M; Biostatistics and Epidemiology Office, Gustave Roussy, Villejuif, France.; Oncostat 1018 INSERM, University Paris-Saclay, Villejuif, France.
Sun R; Department of Radiation Oncology, Gustave Roussy, 114 Rue E. Vaillant, 94850, Villejuif, France.; INSERM U1030, Radiothérapie Moléculaire, Villejuif, France.; Faculty of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, France.
Durand-Labrunie J; Department of Radiation Oncology, Gustave Roussy, 114 Rue E. Vaillant, 94850, Villejuif, France.
Rodriguez-Ruiz ME; Department of Radiation Oncology, Clínica Universidad de Navarrra, Pamplona, Spain.
Racadot S; Department of Radiation Oncology, Centre Léon Bérard, Lyon, France.
Supiot S; Department of Radiation Oncology, Institut de Cancérologie de L'Ouest-Centre Rene Gauducheau, St Herblain, Nantes, France.
Magné N; Department of Radiation Oncology, Institut Bergonié, Bordeaux, France.
Cyrille S; Biostatistics and Epidemiology Office, Gustave Roussy, Villejuif, France.; Oncostat 1018 INSERM, University Paris-Saclay, Villejuif, France.
Louvel G; Department of Radiation Oncology, Gustave Roussy, 114 Rue E. Vaillant, 94850, Villejuif, France.
Massard C; INSERM U1030, Radiothérapie Moléculaire, Villejuif, France.; Faculty of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, France.; Drug Development Department (DITEP), Gustave Roussy-Cancer Campus, Villejuif, France.
Verlingue L; Drug Development Department (DITEP), Gustave Roussy-Cancer Campus, Villejuif, France.
Bouquet F; Product Development Medical Affairs, F Hoffmann-La Roche Ltd, Basel, Switzerland.
Bustillos A; Product Development Medical Affairs, F Hoffmann-La Roche Ltd, Basel, Switzerland.
Bouarroudj L; Department of Radiation Oncology, Gustave Roussy, 114 Rue E. Vaillant, 94850, Villejuif, France.; INSERM U1030, Radiothérapie Moléculaire, Villejuif, France.; Bioinformatic Platform, Gustave Roussy, Villejuif, France.
Quevrin C; INSERM U1030, Radiothérapie Moléculaire, Villejuif, France.
Clémenson C; INSERM U1030, Radiothérapie Moléculaire, Villejuif, France.
Mondini M; INSERM U1030, Radiothérapie Moléculaire, Villejuif, France.
Meziani L; INSERM U1030, Radiothérapie Moléculaire, Villejuif, France.
Tselikas L; Faculty of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, France.; Department of Interventional Radiology, Gustave Roussy, Villejuif, France.
Bahleda R; Drug Development Department (DITEP), Gustave Roussy-Cancer Campus, Villejuif, France.
Hollebecque A; Drug Development Department (DITEP), Gustave Roussy-Cancer Campus, Villejuif, France.
Deutsch E; Department of Radiation Oncology, Gustave Roussy, 114 Rue E. Vaillant, 94850, Villejuif, France. .; INSERM U1030, Radiothérapie Moléculaire, Villejuif, France. .; Faculty of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, France. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2024 Mar 23; Vol. 23 (1), pp. 61. Date of Electronic Publication: 2024 Mar 23.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Colorectal Neoplasms*/radiotherapy
Lung Neoplasms*/drug therapy
Radiosurgery*/adverse effects
Humans ; Male ; Middle Aged ; Antibodies, Monoclonal, Humanized/adverse effects ; Young Adult ; Adult ; Aged ; Aged, 80 and over ; Female

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: [Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
Autorzy:: Li ZM; Zhongshan Cancer Institute, Zhongshan People's Hospital, Zhongshan 528400, China.
Liang ZH; Zhongshan Cancer Institute, Zhongshan People's Hospital, Zhongshan 528400, China.
Liu N; Zhongshan Cancer Institute, Zhongshan People's Hospital, Zhongshan 528400, China.
Wei KR; Zhongshan Cancer Institute, Zhongshan People's Hospital, Zhongshan 528400, China.; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Mar 23; Vol. 46 (3), pp. 232-238.
Typ publikacji:: English Abstract; Journal Article
MeSH Terms:: Nasopharyngeal Neoplasms*
Uterine Neoplasms*
Uterine Cervical Neoplasms*
Liver Neoplasms*
Lung Neoplasms*/epidemiology
Humans ; Male ; Female ; Nasopharyngeal Carcinoma

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: [Cancer incidence and mortality in China, 2022].
Autorzy:: Zheng RS; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Chen R; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Han BF; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang SM; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Li L; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Sun KX; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zeng HM; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wei WW; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
He J; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Mar 23; Vol. 46 (3), pp. 221-231.
Typ publikacji:: English Abstract; Journal Article
MeSH Terms:: Liver Neoplasms*
Lung Neoplasms*
Colorectal Neoplasms*
Male ; Humans ; Female ; Incidence ; Urban Population ; Rural Population ; China/epidemiology ; Registries

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves.
Autorzy:: Dou X; School of Public Health, Dalian Medical University, Dalian 116044, Liaoning, China.
Lu J; School of Public Health, Dalian Medical University, Dalian 116044, Liaoning, China.
Yu Y; School of Public Health, Dalian Medical University, Dalian 116044, Liaoning, China.
Yi Y; School of Public Health, Dalian Medical University, Dalian 116044, Liaoning, China.
Zhou L; School of Public Health, Dalian Medical University, Dalian 116044, Liaoning, China.; Pokaż więcej
Źródło:: Disease markers [Dis Markers] 2024 Mar 21; Vol. 2024, pp. 4782618. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/diagnosis
Male ; Humans ; Female ; Biomarkers, Tumor ; ROC Curve ; Carcinoembryonic Antigen ; Retrospective Studies ; Early Detection of Cancer ; Antigens, Neoplasm ; Keratin-19

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Right upper lobectomy with mediastinal dissection under uniportal video-assisted thoracoscopic surgery for lung cancer in a patient with a right-sided aortic arch: a case report.
Autorzy:: Goto H; Department of General Thoracic Surgery, National Hospital Organization, Saitama Hospital, Suwa 2-1, Wako, Saitama, 351-0102, Japan. .
Nakanishi K; Department of General Thoracic Surgery, National Hospital Organization, Saitama Hospital, Suwa 2-1, Wako, Saitama, 351-0102, Japan.; Pokaż więcej
Źródło:: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Mar 19; Vol. 19 (1), pp. 136. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Male ; Humans ; Aged ; Thoracic Surgery, Video-Assisted ; Aorta, Thoracic/abnormalities ; Pneumonectomy ; Mediastinum/surgery ; Mediastinum/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: An epidermal growth factor receptor compound mutation of L858R with S768I in advanced non-small-cell lung cancer: a case report.
Autorzy:: Boukansa S; Laboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez, Morocco. .; Laboratory of Anatomic Pathology and Molecular Pathology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco. .
Mouhrach I; Unit of Medical Genetics and Oncogenetics, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
El Agy F; Laboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez, Morocco.; Laboratory of Anatomic Pathology and Molecular Pathology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Bouguenouch L; Unit of Medical Genetics and Oncogenetics, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Serraj M; Department of Pneumology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Amara B; Department of Pneumology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Ouadnouni Y; Department of Thoracic Surgery, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Smahi M; Department of Thoracic Surgery, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Alami B; Department of Radiology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Mellas N; Department of Oncology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Benbrahim Z; Department of Oncology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
El Fatemi H; Laboratory of Biomedical and Translational Research, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez, Morocco.; Laboratory of Anatomic Pathology and Molecular Pathology, University Hospital Hassan II, Sidi Mohamed Ben Abdellah University, Fez, Morocco.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2024 Mar 18; Vol. 18 (1), pp. 118. Date of Electronic Publication: 2024 Mar 18.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; Middle Aged ; Clinical Decision-Making ; ErbB Receptors/genetics ; ErbB Receptors/therapeutic use ; Mutation ; Protein Kinase Inhibitors/therapeutic use ; Tyrosine Kinase Inhibitors ; Uncertainty ; Male

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: The preventative effects of statin on lung cancer development in patients with idiopathic pulmonary fibrosis using the National Health Insurance Service Database in Korea.
Autorzy:: Lee YJ; Department of Internal Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea.
Kang N; Department of Statistics and Data Science, Yonsei University, Seoul, Republic of Korea.
Nam J; Department of Internal Medicine, Division of Respiratory, Allergy and Critical Care Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Lee EG; Department of Internal Medicine, Division of Respiratory, Allergy and Critical Care Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
Ryoo J; Department of Internal Medicine, Division of Respiratory, Allergy and Critical Care Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
Kwon SS; Department of Internal Medicine, Division of Respiratory, Allergy and Critical Care Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
Kim YH; Department of Internal Medicine, Division of Respiratory, Allergy and Critical Care Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
Kang HS; Department of Internal Medicine, Division of Respiratory, Allergy and Critical Care Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 13; Vol. 19 (3), pp. e0299484. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/complications
Lung Neoplasms*/epidemiology
Lung Neoplasms*/prevention & control
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Idiopathic Pulmonary Fibrosis*/complications
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/diagnosis
Humans ; Female ; Male ; National Health Programs ; Republic of Korea/epidemiology ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Surgery for pulmonary lesions in patients with a history of urinary tract transitional cell carcinoma.
Autorzy:: Kanzaki R; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan. .
Nagoya A; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Taniguchi S; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Ishida H; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Kimura K; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Fukui E; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Kimura T; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Kanou T; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Ose N; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Funaki S; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Minami M; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Morii E; Department of Pathology, Osaka University Graduate School of Medicine, Suita, Japan.
Shintani Y; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.; Pokaż więcej
Źródło:: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Mar 12; Vol. 19 (1), pp. 117. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Transitional Cell*/pathology
Carcinoma, Transitional Cell*/surgery
Lung Neoplasms*/surgery
Urinary Tract*/pathology
Humans ; Male ; Female ; Aged ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Progress in site-specific cancer mortality in Canada over the last 70 years.
Autorzy:: Warkentin MT; Department of Oncology, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, Canada.
Ruan Y; Department of Oncology, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, Canada.
Ellison LF; Centre for Population Health Data, Statistics Canada, Ottawa, ON, Canada.
Billette JM; Centre for Population Health Data, Statistics Canada, Ottawa, ON, Canada.
Demers A; Adult Chronic Diseases and Conditions Division, Public Health Agency of Canada, Ottawa, ON, Canada.
Liu FF; Institute of Cancer Research, Canadian Institutes of Health Research, Ottawa, ON, Canada.
Brenner DR; Department of Oncology, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, Canada. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 07; Vol. 14 (1), pp. 5688. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplasms*
Lung Neoplasms*
Leukemia*
Male ; Humans ; Female ; Canada/epidemiology ; Breast ; Life Style ; Mortality ; Incidence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: The effect of spread through air spaces on postoperative recurrence-free survival in patients with multiple primary lung cancers.
Autorzy:: Xie H; The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong, China.
Dou S; Department of Thoracic Surgery, the First Affiliated Hospital of Hainan Medical College, Haikou, China.
Huang X; The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong, China.
Wen Y; Department of Thoracic surgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.
Yang L; The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong, China. .; Department of Thoracic surgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China. .; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2024 Mar 05; Vol. 22 (1), pp. 75. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/surgery
Neoplasms, Multiple Primary*
Female ; Male ; Humans ; Retrospective Studies ; Hospitals ; Multivariate Analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: The insufficiency of CT examination in early detection of central lung squamous cell carcinoma and squamous epithelial precancerous lesions.
Autorzy:: Zhou J; Department of Endoscopy, Zhejiang Cancer Hospital, Hangzhou, China.
Yu B; Department of Endoscopy, Zhejiang Cancer Hospital, Hangzhou, China.
Guo P; Department of Endoscopy, Zhejiang Cancer Hospital, Hangzhou, China.
Wang S; Department of Endoscopy, Zhejiang Cancer Hospital, Hangzhou, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 05; Vol. 24 (1), pp. 299. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*
Carcinoma, Squamous Cell*/diagnostic imaging
Lung Neoplasms*/diagnostic imaging
Precancerous Conditions*/diagnostic imaging
Aged ; Female ; Middle Aged ; Humans ; Male ; Lymphatic Metastasis ; Retrospective Studies ; Early Detection of Cancer ; Lung

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Male"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język